AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2024
May 7, 2024
34491_dirs_2024-05-07_7dcd4e41-7ad7-4866-bf64-401be8594bab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2024-05-04
Reporting Person: Pire Shari Lisa (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-04 | Common Stock | M | 4202 | — | Acquired | 4202 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-04 | Restricted Stock Units | $ | M | 4202 | Disposed | Common Stock (4202) | Direct |
Footnotes
F1: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024.
F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split.
F4: On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19